• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视觉功能障碍比视网膜厚度更能预测帕金森病患者的痴呆。

Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson's disease.

机构信息

Dementia Research Centre, Institute of Neurology, University College London, London, UK.

National Hospital for Neurology and Neurosurgery, University College London Hospitals, London, UK.

出版信息

J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):742-750. doi: 10.1136/jnnp-2023-331083. Epub 2023 Apr 20.

DOI:10.1136/jnnp-2023-331083
PMID:37080759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10447370/
Abstract

BACKGROUND

Dementia is a common and devastating symptom of Parkinson's disease (PD). Visual function and retinal structure are both emerging as potentially predictive for dementia in Parkinson's but lack longitudinal evidence.

METHODS

We prospectively examined higher order vision (skew tolerance and biological motion) and retinal thickness (spectral domain optical coherence tomography) in 100 people with PD and 29 controls, with longitudinal cognitive assessments at baseline, 18 months and 36 months. We examined whether visual and retinal baseline measures predicted longitudinal cognitive scores using linear mixed effects models and whether they predicted onset of dementia, death and frailty using time-to-outcome methods.

RESULTS

Patients with PD with poorer baseline visual performance scored lower on a composite cognitive score (β=0.178, SE=0.05, p=0.0005) and showed greater decreases in cognition over time (β=0.024, SE=0.001, p=0.013). Poorer visual performance also predicted greater probability of dementia (χ² (1)=5.2, p=0.022) and poor outcomes (χ² (1) =10.0, p=0.002). Baseline retinal thickness of the ganglion cell-inner plexiform layer did not predict cognitive scores or change in cognition with time in PD (β=-0.013, SE=0.080, p=0.87; β=0.024, SE=0.001, p=0.12).

CONCLUSIONS

In our deeply phenotyped longitudinal cohort, visual dysfunction predicted dementia and poor outcomes in PD. Conversely, retinal thickness had less power to predict dementia. This supports mechanistic models for Parkinson's dementia progression with onset in cortical structures and shows potential for visual tests to enable stratification for clinical trials.

摘要

背景

痴呆是帕金森病(PD)的常见且具有破坏性的症状。视觉功能和视网膜结构都可能成为帕金森痴呆的预测指标,但缺乏纵向证据。

方法

我们前瞻性地检查了 100 名 PD 患者和 29 名对照者的高级视觉(斜视容忍度和生物运动)和视网膜厚度(谱域光学相干断层扫描),并在基线、18 个月和 36 个月进行了纵向认知评估。我们使用线性混合效应模型检查了视觉和视网膜基线测量值是否可以预测纵向认知评分,以及它们是否可以使用时间到结果方法预测痴呆、死亡和虚弱的发生。

结果

PD 患者的基线视觉表现越差,综合认知评分越低(β=0.178,SE=0.05,p=0.0005),并且认知随时间的下降幅度越大(β=0.024,SE=0.001,p=0.013)。较差的视觉表现也预测了更高的痴呆(χ²(1)=5.2,p=0.022)和不良结局(χ²(1)=10.0,p=0.002)的发生概率。PD 患者的神经节细胞-内丛状层的视网膜厚度基线值不能预测认知评分或认知随时间的变化(β=-0.013,SE=0.080,p=0.87;β=0.024,SE=0.001,p=0.12)。

结论

在我们深入表型的纵向队列中,视觉功能障碍预测了 PD 中的痴呆和不良结局。相反,视网膜厚度预测痴呆的能力较弱。这支持了帕金森痴呆进展的机制模型,其起始于皮质结构,并显示出视觉测试在临床试验中分层的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/ee05327ce07e/jnnp-2023-331083f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/3d23f0f464c2/jnnp-2023-331083f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/ce8ec7b6102b/jnnp-2023-331083f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/81192c18ef4d/jnnp-2023-331083f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/ee05327ce07e/jnnp-2023-331083f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/3d23f0f464c2/jnnp-2023-331083f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/ce8ec7b6102b/jnnp-2023-331083f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/81192c18ef4d/jnnp-2023-331083f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167f/10447370/ee05327ce07e/jnnp-2023-331083f04.jpg

相似文献

1
Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson's disease.视觉功能障碍比视网膜厚度更能预测帕金森病患者的痴呆。
J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):742-750. doi: 10.1136/jnnp-2023-331083. Epub 2023 Apr 20.
2
Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases.周边部视网膜内层变薄与路易体病的视觉功能障碍有关。
Mov Disord. 2019 Sep;34(9):1315-1324. doi: 10.1002/mds.27728. Epub 2019 May 28.
3
Dynamics of retinal changes in early-stage Parkinson's disease.早期帕金森病视网膜变化的动态研究
Acta Neuropathol Commun. 2025 Jan 31;13(1):20. doi: 10.1186/s40478-025-01936-x.
4
Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study.帕金森病患者视网膜神经纤维层厚度与认知进展的相关性:一项纵向研究。
Parkinsonism Relat Disord. 2021 Jan;82:92-97. doi: 10.1016/j.parkreldis.2020.11.025. Epub 2020 Nov 28.
5
Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.阿尔茨海默病患者视网膜神经纤维层变薄:与正常衰老、帕金森病和非阿尔茨海默病痴呆症的病例对照研究
Am J Alzheimers Dis Other Demen. 2016 Aug;31(5):430-6. doi: 10.1177/1533317515628053. Epub 2016 Feb 16.
6
Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.视网膜结构变化和血清高迁移率族蛋白 B1 水平与帕金森病患者认知功能下降有关。
Neurobiol Dis. 2024 Jan;190:106379. doi: 10.1016/j.nbd.2023.106379. Epub 2023 Dec 15.
7
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease.视觉功能障碍可预测帕金森病患者的认知障碍和白质退化。
Mov Disord. 2021 May;36(5):1191-1202. doi: 10.1002/mds.28477. Epub 2021 Jan 9.
8
Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.脑脊液 GFAP 是预测首发帕金森病患者向痴呆和阿尔茨海默病相关生物标志物改变转化的生物标志物:一项前瞻性队列研究。
J Neuroinflammation. 2023 Jul 20;20(1):167. doi: 10.1186/s12974-023-02843-5.
9
Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.帕金森病患者的视觉功能障碍及其与视网膜变化的相关性:一项观察性横断面研究。
BMJ Open. 2016 May 6;6(5):e009658. doi: 10.1136/bmjopen-2015-009658.
10
Visual tests predict dementia risk in Parkinson disease.视力测试可预测帕金森病的痴呆风险。
Neurol Clin Pract. 2020 Feb;10(1):29-39. doi: 10.1212/CPJ.0000000000000719.

引用本文的文献

1
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.路易体痴呆亚型的神经影像学和血浆生物标志物差异与共性
Alzheimers Dement. 2025 May;21(5):e70274. doi: 10.1002/alz.70274.
2
Modulatory effect of levodopa on the basal ganglia-cerebellum connectivity in Parkinson's disease.左旋多巴对帕金森病基底神经节 - 小脑连接性的调节作用。
NPJ Parkinsons Dis. 2025 May 6;11(1):115. doi: 10.1038/s41531-025-00954-9.
3
Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.

本文引用的文献

1
Structural and functional changes in the retina in Parkinson's disease.帕金森病患者视网膜的结构和功能变化。
J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):448-456. doi: 10.1136/jnnp-2022-329342. Epub 2023 Feb 17.
2
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
3
Determinants of Medical Direct Costs of Care among Patients of a Memory Center.记忆中心患者医疗直接成本的决定因素。
基于神经影像学的帕金森病所致时空萎缩的数据驱动亚型
Brain Commun. 2025 Apr 16;7(2):fcaf146. doi: 10.1093/braincomms/fcaf146. eCollection 2025.
4
Differential cognitive functioning in the digital clock drawing test in AD-MCI and PD-MCI populations.AD-MCI和PD-MCI人群在数字时钟绘制测试中的认知功能差异。
Front Neurosci. 2025 Mar 13;19:1558448. doi: 10.3389/fnins.2025.1558448. eCollection 2025.
5
Dynamics of retinal changes in early-stage Parkinson's disease.早期帕金森病视网膜变化的动态研究
Acta Neuropathol Commun. 2025 Jan 31;13(1):20. doi: 10.1186/s40478-025-01936-x.
6
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.神经影像学和液体生物标志物在靶向干预时代的帕金森病。
Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9.
7
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patients.帕金森病患者血液中的聚集抗性α-突触核蛋白四聚体减少。
EMBO Mol Med. 2024 Jul;16(7):1657-1674. doi: 10.1038/s44321-024-00083-5. Epub 2024 Jun 5.
8
Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes.帕金森病早期白质丢失与不良预后的神经影像学及血浆证据。
Brain Commun. 2024 Apr 16;6(3):fcae130. doi: 10.1093/braincomms/fcae130. eCollection 2024.
9
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson's disease.视网膜神经变性与帕金森病认知功能减退进展的关联
NPJ Parkinsons Dis. 2024 Jan 23;10(1):26. doi: 10.1038/s41531-024-00637-x.
10
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.帕金森病认知障碍的病理生物学:挑战与展望。
Int J Mol Sci. 2023 Dec 29;25(1):498. doi: 10.3390/ijms25010498.
J Prev Alzheimers Dis. 2021;8(3):351-361. doi: 10.14283/jpad.2021.16.
4
Sequence of clinical and neurodegeneration events in Parkinson's disease progression.帕金森病进展中的临床和神经退行性变事件序列。
Brain. 2021 Apr 12;144(3):975-988. doi: 10.1093/brain/awaa461.
5
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease.视觉功能障碍可预测帕金森病患者的认知障碍和白质退化。
Mov Disord. 2021 May;36(5):1191-1202. doi: 10.1002/mds.28477. Epub 2021 Jan 9.
6
Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study.帕金森病患者视网膜神经纤维层厚度与认知进展的相关性:一项纵向研究。
Parkinsonism Relat Disord. 2021 Jan;82:92-97. doi: 10.1016/j.parkreldis.2020.11.025. Epub 2020 Nov 28.
7
Central retina changes in Parkinson's disease: a systematic review and meta-analysis.帕金森病的中心视网膜改变:系统评价和荟萃分析。
J Neurol. 2021 Dec;268(12):4646-4654. doi: 10.1007/s00415-020-10304-9. Epub 2020 Nov 10.
8
Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease.视网膜厚度可预测帕金森病患者认知能力下降的风险。
Ann Neurol. 2021 Jan;89(1):165-176. doi: 10.1002/ana.25944. Epub 2020 Nov 9.
9
Visual Acuity and Development of Parkinson's Disease: A Nationwide Cohort Study.视力与帕金森病发病:全国队列研究。
Mov Disord. 2020 Sep;35(9):1532-1541. doi: 10.1002/mds.28184. Epub 2020 Jul 25.
10
Visual Impairment Is More Common in Parkinson's Disease and Is a Risk Factor for Poor Health Outcomes.视力障碍在帕金森病中更为常见,是健康状况不佳的一个风险因素。
Mov Disord. 2020 Sep;35(9):1542-1549. doi: 10.1002/mds.28182. Epub 2020 Jul 14.